All In Biotech

Drug Trial Radar · NCT00070304

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

A Phase II Study Of Weekly Gemcitabine And Vinorelbine In Children With Recurrent Or Refractory Hodgkin's Disease

Last checked: Nov 20, 2026Latest source record: Jul 26, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

33

Actual

Start

Jul 2004

Primary completion

Sep 2007

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Oct 7, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy, such as gemcitabine and vinorelbine, use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving gemcitabine together with vinorelbine works in treating young patients with recurrent or refractory Hodgkin's lymphoma.

Conditions

  • Lymphoma

Interventions

  • filgrastimBiological

    Given by mouth or IV, 5 micrograms/kg/dose (up to 10 micrograms/kg/dose) daily starting on day 9 for a minimum of 7 days and until the ANC is greater to or equal to 1,500/uL.

  • gemcitabine hydrochlorideDrug

    Given IV over 100 minutes dose 1000 mg/m2/dose in 500 ml NS on days 1 and 8

  • vinorelbine tartrateDrug

    Given IV over 6-10 minutes (central venous catheter). Dose 25 mg/m2/dose on days 1 and 8

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tumor Response RateTime frame: Up to 1 year

Locations

123 sites in 5 countries. Site status is shown where the registry gives one.

  • Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham

    Birmingham, Alabama

  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Southern California Permanente Medical Group

    Downey, California

  • Loma Linda University Cancer Institute at Loma Linda University Medical Center

    Loma Linda, California

  • Jonsson Comprehensive Cancer Center at UCLA

    Los Angeles, California

  • Children's Hospital Central California

    Madera, California

  • Kaiser Permanente Medical Center - Oakland

    Sacramento, California

  • Children's Hospital and Health Center - San Diego

    San Diego, California

  • UCSF Comprehensive Cancer Center

    San Francisco, California

  • Stanford Comprehensive Cancer Center - Stanford

    Stanford, California

  • Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center

    Farmington, Connecticut

  • Alfred I. duPont Hospital for Children

    Wilmington, Delaware

  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center

    Washington D.C., District of Columbia

  • Lee Cancer Care of Lee Memorial Health System

    Fort Myers, Florida

  • University of Florida Shands Cancer Center

    Gainesville, Florida

  • Nemours Children's Clinic

    Jacksonville, Florida

  • University of Miami Sylvester Comprehensive Cancer Center

    Miami, Florida

  • Miami Children's Hospital

    Miami, Florida

  • Florida Hospital Cancer Institute at Florida Hospital Orlando

    Orlando, Florida

  • Nemours Children's Clinic - Orlando

    Orlando, Florida

  • Sacred Heart Cancer Center at Sacred Heart Hospital

    Pensacola, Florida

  • All Children's Hospital

    St. Petersburg, Florida

  • St. Joseph's Cancer Institute at St. Joseph's Hospital

    Tampa, Florida

  • Kaplan Cancer Center at St. Mary's Medical Center

    West Palm Beach, Florida

  • Winship Cancer Institute of Emory University

    Atlanta, Georgia

  • Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center

    Savannah, Georgia

  • Cancer Research Center of Hawaii

    Honolulu, Hawaii

  • Children's Memorial Hospital - Chicago

    Chicago, Illinois

  • Southern Illinois University School of Medicine

    Springfield, Illinois

  • Indiana University Cancer Center

    Indianapolis, Indiana

  • St. Vincent Indianapolis Hospital

    Indianapolis, Indiana

  • Blank Children's Hospital

    Des Moines, Iowa

  • Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center

    Kansas City, Kansas

  • Markey Cancer Center at University of Kentucky Chandler Medical Center

    Lexington, Kentucky

  • Kosair Children's Hospital

    Louisville, Kentucky

  • CancerCare of Maine at Eastern Maine Medial Center

    Bangor, Maine

  • Maine Children's Cancer Program

    Scarborough, Maine

  • Alvin and Lois Lapidus Cancer Institute at Sinai Hospital

    Baltimore, Maryland

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland

  • Floating Hospital for Children at Tufts - New England Medical Center

    Boston, Massachusetts

Showing 40 of 123 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.